CBUS
Price
$4.90
Change
-$0.41 (-7.72%)
Updated
Nov 13 closing price
MGTX
Price
$7.04
Change
+$0.38 (+5.71%)
Updated
Nov 13 closing price
118 days until earnings call
Ad is loading...

CBUS vs MGTX

Header iconCBUS vs MGTX Comparison
Open Charts CBUS vs MGTXBanner chart's image
Cibus
Price$4.90
Change-$0.41 (-7.72%)
Volume$135.44K
CapitalizationN/A
MeiraGTx Holdings
Price$7.04
Change+$0.38 (+5.71%)
Volume$342.82K
CapitalizationN/A
CBUS vs MGTX Comparison Chart
Loading...
CBUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CBUS vs. MGTX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CBUS is a StrongSell and MGTX is a Buy.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (CBUS: $4.90 vs. MGTX: $7.04)
Brand notoriety: CBUS and MGTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CBUS: 57% vs. MGTX: 110%
Market capitalization -- CBUS: $129.63M vs. MGTX: $514.05M
CBUS [@Biotechnology] is valued at $129.63M. MGTX’s [@Biotechnology] market capitalization is $514.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CBUS’s FA Score shows that 1 FA rating(s) are green whileMGTX’s FA Score has 0 green FA rating(s).

  • CBUS’s FA Score: 1 green, 4 red.
  • MGTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both CBUS and MGTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CBUS’s TA Score shows that 5 TA indicator(s) are bullish while MGTX’s TA Score has 6 bullish TA indicator(s).

  • CBUS’s TA Score: 5 bullish, 4 bearish.
  • MGTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MGTX is a better buy in the short-term than CBUS.

Price Growth

CBUS (@Biotechnology) experienced а +6.29% price change this week, while MGTX (@Biotechnology) price change was +9.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

CBUS is expected to report earnings on Aug 09, 2023.

MGTX is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MGTX($514M) has a higher market cap than CBUS($130M). MGTX YTD gains are higher at: 0.285 vs. CBUS (-75.051). MGTX has higher annual earnings (EBITDA): -65.93M vs. CBUS (-326.77M). MGTX has more cash in the bank: 100M vs. CBUS (30M). CBUS has less debt than MGTX: CBUS (37.7M) vs MGTX (87.6M). MGTX has higher revenues than CBUS: MGTX (8.12M) vs CBUS (2.96M).
CBUSMGTXCBUS / MGTX
Capitalization130M514M25%
EBITDA-326.77M-65.93M496%
Gain YTD-75.0510.285-26,343%
P/E RatioN/AN/A-
Revenue2.96M8.12M36%
Total Cash30M100M30%
Total Debt37.7M87.6M43%
FUNDAMENTALS RATINGS
CBUS vs MGTX: Fundamental Ratings
CBUS
MGTX
OUTLOOK RATING
1..100
1628
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9797
PRICE GROWTH RATING
1..100
6336
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
5048

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CBUS's Valuation (25) in the null industry is somewhat better than the same rating for MGTX (63) in the Biotechnology industry. This means that CBUS’s stock grew somewhat faster than MGTX’s over the last 12 months.

CBUS's Profit vs Risk Rating (100) in the null industry is in the same range as MGTX (100) in the Biotechnology industry. This means that CBUS’s stock grew similarly to MGTX’s over the last 12 months.

CBUS's SMR Rating (97) in the null industry is in the same range as MGTX (97) in the Biotechnology industry. This means that CBUS’s stock grew similarly to MGTX’s over the last 12 months.

MGTX's Price Growth Rating (36) in the Biotechnology industry is in the same range as CBUS (63) in the null industry. This means that MGTX’s stock grew similarly to CBUS’s over the last 12 months.

MGTX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as CBUS (100) in the null industry. This means that MGTX’s stock grew similarly to CBUS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CBUSMGTX
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
Bullish Trend 4 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 22 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Ad is loading...
CBUS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
MGTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AWSIX17.44-0.04
-0.23%
Invesco Global Core Equity R5
FCCVX36.21-0.10
-0.28%
Fidelity Advisor Convertible Secs C
FCGIX20.85-0.07
-0.33%
NYLI PineStone Global Equity Class I
FDGFX39.67-0.27
-0.68%
Fidelity Dividend Growth
MMSCX11.43-0.10
-0.87%
Praxis Small Cap Index A

CBUS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBUS has been loosely correlated with VRDN. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CBUS jumps, then VRDN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBUS
1D Price
Change %
CBUS100%
-7.72%
VRDN - CBUS
34%
Loosely correlated
+0.31%
QSI - CBUS
32%
Poorly correlated
+2.05%
MGTX - CBUS
31%
Poorly correlated
+5.71%
ETNB - CBUS
31%
Poorly correlated
-1.49%
RXRX - CBUS
30%
Poorly correlated
-3.56%
More

MGTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+5.71%
NTLA - MGTX
51%
Loosely correlated
-3.24%
BEAM - MGTX
49%
Loosely correlated
-1.57%
EDIT - MGTX
48%
Loosely correlated
-3.58%
CRSP - MGTX
47%
Loosely correlated
-1.85%
ACLX - MGTX
47%
Loosely correlated
-0.34%
More